DYSKERATOSIS CONGENITA
Two regulation points for differentiation in the cell cycle of human megakaryocytes
Generation of human natural killer cells from peripheral blood CD34+ cells mobilized by granulocyte colony-stimulating factor
Characterization of peripheral blood progenitor cells (PBPC) mobilized by filgrastim (rHuG-CSF) in normal volunteers
The regulation of neutrophil phospholipase A2 by granulocyte-macrophage colony-stimulating factor and its role in priming superoxide production
Serum erythropoietin levels in paroxysmal nocturnal haemoglobinuria
Splenectomy as an adjuvant measure in the treatment of severe aplastic anaemia
Five unknown mutations in the LR pyruvate kinase gene associated with severe hereditary nonspherocytic haemolytic anaemia in France
A case of refractory anaemia with p53 point mutation at codon 249 (AGG to ATG)
Plateau phase in multiple myeloma
Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients
Levels of mdr 1 and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogenous and inversely correlated to cellular daunorubicin accumulation
Molecular detection of t(8;21)/AML1-ETO in AML M1/M2
NPM/ALK gene fusion transcripts identify a distinct subgroup of null type Ki-1 positive anaplastic large cell lymphomas
Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice
The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma
Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome
Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas
Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-Hodgkin's lymphoma undergoing cytoreductive chemotherapy
Bone marrow transplantation from partially HLA-matched related donors in adults with leukaemia
Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia
Acute myeloid and T-cell acute lymphoblastic leukaemia with aberrant antigen expression exhibit similar TCRδ gene rearrangements
All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri
Cytogenetic remission induced by interferon-α in a myeloproliferative disorder with trisomy 8
Karyotype conversion in two patients with chronic myeloid leukaemia after busulphan-induced marrow hypoplasia
Human herpesvirus-6-associated exanthema in a patient with acute lymphocytic leukaemia
Leukaemic CD5+ B-cell apoptosis
Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia
Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies
Physiologic concentrations of arginine vasopressin activate human platelets in vitro
The impact of prophylactic treatment on children with severe haemophilia
Development and clinical application of a new ELISA assay to determine plasmin-α2-antiplasmin complexes in plasma
Characterization of a large chromosomal deletion in the PROS 1 gene of a patient with protein S deficiency type I using long PCR
Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism
HELLP syndrome associated with factor V R506Q mutation
rVIIa therapy to secure haemostasis during central line insertion in children with high-responding FVIII inhibitors
A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions
Evidence of involvement of cytotoxic antibodies directed against patient's HLA class II produced by transfused donor-derived B cells in post-transfusion graft-versus-host disease
Elevated serum interleukin-6 (IL-6) is derived from neoplastic lymphoid cells in patients with B-cell non-Hodgkin's lymphoma
Evidence for a single origin of factor V Leiden
Blood
Self-Assessment Colour Review of Clinical Haematology.